{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:03:06Z","timestamp":1780984986423,"version":"3.54.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Botulinum toxin type A (BoNT-A) is widely used in aesthetic dermatology, particularly for dynamic wrinkles in the upper facial third. Beyond cosmetic effects, BoNT-A may influence emotional processing through the skin-brain axis. This narrative review synthesizes evidence on psychological and psychiatric outcomes of upper facial BoNT-A treatment, with a focus on mechanisms extending beyond aesthetics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A structured search was conducted in PubMed, Scopus, and Web of Science through January 2026. Search terms included \u201cbotulinum toxin,\u201d \u201cupper facial third,\u201d \u201cpsychodermatology,\u201d \u201cfacial feedback,\u201d \u201cdepression,\u201d \u201canxiety,\u201d and \u201cpsychiatric disorders.\u201d Original studies, randomized controlled trials (RCTs), observational studies, systematic reviews, and meta-analyses assessing psychological, psychiatric, or neurobiological outcomes were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Upper facial BoNT-A is associated with clinically meaningful reductions in depressive and anxiety symptoms, and improvements in self-perception and social functioning. Inhibition of corrugator and procerus muscles modulates afferent signaling to limbic structures, supporting the facial feedback hypothesis. Neuroimaging evidence demonstrates attenuated amygdala activation after BoNT-A treatment. Psychosocial improvements may reinforce these neurobiological effects. Evidence in bipolar disorder and personality disorders remains limited and methodologically heterogeneous. Caution is advised in patients with body dysmorphic disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>BoNT-A in the upper facial third provides psychodermatological benefits beyond aesthetics, improving emotional regulation and affective symptoms. It should be considered a complementary intervention within a biopsychosocial framework. Future large-scale RCTs with standardized psychiatric and neurobiological endpoints are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1822916","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:41:02Z","timestamp":1780983662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond aesthetic outcomes: psychodermatological benefits of botulinum toxin treatment in the upper facial third. A narrative review"],"prefix":"10.3389","volume":"17","author":[{"given":"\u00c1lvaro","family":"Loewen","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University Hospital Fundaci\u00f3n Jim\u00e9nez D\u00edaz","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Aranda-Guerrero","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University Hospital Puerta de Hierro Majadahonda","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tajima-Pozo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University Hospital Fundaci\u00f3n Alcorc\u00f3n","place":["Madrid, Spain"]},{"name":"Department of AMIR Aesthetic Medicine, Healthcademia Education Group","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000475758.63709.23","article-title":"Global aesthetics consensus: Botulinum toxin type A--evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications","volume":"137","author":"Sundaram","year":"2016","journal-title":"Plast Reconstructive Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14720","DOI":"10.1038\/s41598-018-33119-1","article-title":"The interactions between botulinum-toxin-based facial treatments and embodied emotions","volume":"8","author":"Lewis","year":"2018","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2022.08.063","article-title":"Impact of botulinum toxin for facial aesthetics on psychological well-being and quality of life: Evidence-based review","volume":"75","author":"Pereira","year":"2022","journal-title":"J Plastic Reconstructive Aesthetic Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01795.x","article-title":"A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type A injections on quality of life and self-esteem","volume":"36","author":"Dayan","year":"2010","journal-title":"Dermatologic Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.10.649","article-title":"Botulinum toxin and the facial feedback hypothesis: Can looking better make you feel happier","volume":"58","author":"Alam","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14328","article-title":"Skin and psychosomatics - psychodermatology today","volume":"18","author":"Gieler","year":"2020","journal-title":"J der Deutschen Dermatologischen Gesellschaft"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cells12141828","article-title":"Mens sana in cute sana\"\u2014a state of the art of mutual etiopathogenetic influence and relevant pathophysiological pathways between skin and mental disorders: An integrated approach to contemporary psychopathological scenarios","volume":"12","author":"Papa","year":"2023","journal-title":"Cells"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.03.008","article-title":"Stress-induced interaction of skin immune cells, hormones, and neurotransmitters","volume":"42","author":"Pondeljak","year":"2020","journal-title":"Clin Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000009240","article-title":"Glabellar botulinum toxin injection improves depression scores: A systematic review and meta-analysis","volume":"150","author":"Crowley","year":"2022","journal-title":"Plast Reconstructive Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S181820","article-title":"Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm","volume":"15","author":"Dong","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15050336","article-title":"Botulinum toxin treatment for depression: A new paradigm for psychiatry","volume":"15","author":"Finzi","year":"2023","journal-title":"Toxins"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2023.107148","article-title":"Depression roundtable: Is there a role for BoNT","volume":"229","author":"Kels","year":"2023","journal-title":"Toxicon"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2021.01.016","article-title":"Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis","volume":"135","author":"Schulze","year":"2021","journal-title":"J Psychiatr Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v67n0105","article-title":"Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: A placebo-controlled double-blind trial","volume":"67","author":"Connor","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"24173","DOI":"10.1038\/s41598-021-03713-x","article-title":"Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety","volume":"11","author":"Wollmer","year":"2021","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhn104","article-title":"The link between facial feedback and neural activity within central circuitries of emotion\u2014new insights from botulinum toxin-induced denervation of frown muscles","volume":"19","author":"Hennenlotter","year":"2009","journal-title":"Cereb Cortex"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1038\/s41598-023-29280-x","article-title":"Modulation of amygdala activity for emotional faces due to botulinum toxin type A injections that prevent frowning","volume":"13","author":"Stark","year":"2023","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/toxins16040191","article-title":"Botulinum toxin injections for psychiatric disorders: A systematic review of the clinical trial landscape","volume":"16","author":"Demchenko","year":"2024","journal-title":"Toxins"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.06.015","article-title":"Botulinum toxin therapy of bipolar depression: A case series","volume":"104","author":"Finzi","year":"2018","journal-title":"J Psychiatr Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-018-1165-3","article-title":"Body image, personality traits, and quality of life in botulinum toxin A and dermal filler patients","volume":"42","author":"Scharschmidt","year":"2018","journal-title":"Aesthetic Plast Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00406-023-01563-4","article-title":"Effects of glabellar botulinum toxin injections on resting-state functional connectivity in borderline personality disorder","volume":"274","author":"Schulze","year":"2024","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.01.158","article-title":"Comparative effectiveness of two different doses of botulinum toxin A for the treatment of mild to moderate depression","volume":"350","author":"Shu","year":"2024","journal-title":"J Affect Disord"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211069108","article-title":"Clinical effects of glabellar botulinum toxin\u00a0injections on borderline personality disorder: A randomized controlled trial","volume":"36","author":"Wollmer","year":"2022","journal-title":"J\u00a0Psychopharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jdermsci.2025.06.001","article-title":"Healthy skin, healthy brain","volume":"119","author":"Yoon","year":"2025","journal-title":"J Dermatol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137484","article-title":"Probing the skin-brain axis: New vistas using mouse models","volume":"23","author":"Weiglein","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1037\/bul0000194","article-title":"A meta-analysis of the facial feedback literature: Effects of facial feedback on emotional experience are small and variable","volume":"145","author":"Coles","year":"2019","journal-title":"psychol Bull"},{"key":"B27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.autneu.2013.06.009","article-title":"An amplification of feedback from facial muscles strengthened sympathetic activations to emotional facial cues","volume":"179","author":"Lee","year":"2013","journal-title":"Autonomic Neuroscience: Basic Clin"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41562-022-01458-9","article-title":"A multi-lab test of the facial feedback hypothesis by the Many Smiles Collaboration","volume":"6","author":"Coles","year":"2022","journal-title":"Nat Hum Behav"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10919-017-0264-1","article-title":"How the experience of emotion is modulated by facial feedback","volume":"42","author":"S\u00f6derkvist","year":"2018","journal-title":"J Nonverbal Behav"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1037\/emo0000717","article-title":"Does facial action modulate neural responses of emotion? An examination with the late positive potential (LPP)","volume":"21","author":"Yu","year":"2021","journal-title":"Emotion (Washington DC)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032372","article-title":"Botox (onabotulinumtoxinA) mechanism of action","volume":"102","author":"Brin","year":"2023","journal-title":"Medicine"},{"key":"B32","unstructured":"BOTOX Cosmetic (onabotulinumtoxinA)\n          \n          \n          \n          2024"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-013-0178-1","article-title":"Understanding the functional\u00a0anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy","volume":"37","author":"Lorenc","year":"2013","journal-title":"Aesthetic Plast Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjac253","article-title":"The efficacy and duration of onabotulinum toxin A in improving upper facial expression lines with 64-unit dose optimization: A systematic review and meta-analysis with trial sequential analysis of the randomized controlled trials","volume":"43","author":"Rahman","year":"2023","journal-title":"Aesthetic Surg J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/toxins17120603","article-title":"Why, when, and how to treat dynamic forehead lines with botulinum toxin type A","volume":"17","author":"de Sanctis Pecora","year":"2025","journal-title":"Toxins"},{"key":"B36","doi-asserted-by":"publisher","first-page":"14197","DOI":"10.1038\/s41598-022-17509-0","article-title":"Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder","volume":"12","author":"Kruger","year":"2022","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5414\/cpp39460","article-title":"Botulinophilia: Contraindication for therapy with botulinum toxin","volume":"39","author":"Harth","year":"2001","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/1177925","article-title":"OnabotulinumtoxinA in resistant depression: A randomized trial comparing two facial injection sites (OnaDEP Study)","volume":"2024","author":"Ceolato-Martin","year":"2024","journal-title":"Depression Anxiety"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001066","article-title":"Botulinum toxin therapy of social anxiety disorder: A case series","volume":"39","author":"Finzi","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-005-0150-9","article-title":"Psychosocial aspects of Botox in aesthetic surgery","volume":"30","author":"Singh","year":"2006","journal-title":"Aesthetic Plast Surg"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000242500.28431.24","article-title":"Body dysmorphic disorder and cosmetic surgery","volume":"118","author":"Crerand","year":"2006","journal-title":"Plast Reconstructive Surg"},{"key":"B42","volume-title":"Diagnostic and statistical manual of mental disorders","year":"2022"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1822916\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:41:15Z","timestamp":1780983675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1822916\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":42,"alternative-id":["10.3389\/fpsyt.2026.1822916"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1822916","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"article-number":"1822916"}}